GRAL Competitors & Alternatives
Compare GRAIL, LLC with similar stocks in the same industry
Diagnostics & Research
GRAL
Main Stock$105.60
-8.88%
Tradestie Score
55
Market Cap
$2.24B
Revenue Growth
3.7%
Analyst Upside
+32.0%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 7/10
Genomics Precision Med
Genomic Sequencing
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
RVMD
Revolution Medicines, Inc. Common Stock
|
$166.87
-3.15%
|
$8.57B | - | 44 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$335.52
-0.72%
|
$8.39B | 367.4 | 45 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$144.03
-5.06%
|
$7.81B | - | 48 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$76.89
+0.62%
|
$6.00B | - | 45 | Compare |
|
BLLN
BLLN
|
$96.31
-8.41%
|
$5.02B | 114.3 | 35 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$16.25
-2.17%
|
$4.60B | 27.7 | 60 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$51.02
-2.58%
|
$3.26B | - | 50 | Compare |
|
VCYT
Veracyte, Inc.
|
$24.01
-1.32%
|
$2.85B | 15.8 | 47 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$27.87
-4.03%
|
$2.22B | - | 45 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$105.04
-5.88%
|
$1.77B | - | 52 | Compare |
More GRAL Analysis
Data updated: Nov 16, 2026 | Industry: Diagnostics & Research (SIC 8071)
37 stocks in this industry